DOI: 10.5061/dryad.269k8
title: Data from: The rise of health biotechnology research in Latin America: a scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico.

description: This paper analyzes the patterns of health biotechnology publications in
 six Latin American countries from 2001 to 2015. The countries studied were
 Argentina, Brazil, Chile, Colombia, Cuba and Mexico. Before our study,
 there were no data available on HBT development in half of the
 Latin-American countries we studied, i.e., Argentina, Colombia and Chile.
 To include these countries in a scientometric analysis of HBT provides
 fuller coverage of HBT development in Latin America. The scientometric
 study used the Web of Science database to identify health biotechnology
 publications. The total amount of health biotechnology production in the
 world during the period studied was about 400,000 papers. A total of 1.2%
 of these papers, were authored by the six Latin American countries in this
 study. The results show a significant growth in health biotechnology
 publications in Latin America despite some of the countries having social
 and political instability, fluctuations in their gross domestic
 expenditure in research and development or a trade embargo that limits
 opportunities for scientific development. The growth in the field of some
 of the Latin American countries studied was larger than the growth of most
 industrialized nations. Still, the visibility of the Latin American
 research (measured in the number of citations) did not reach the world
 average, with the exception of Colombia. The main producers of health
 biotechnology papers in Latin America were universities, except in Cuba
 were governmental institutions were the most frequent producers. The
 countries studied were active in international research collaboration with
 Colombia being the most active (64% of papers co-authored
 internationally), whereas Brazil was the least active (35% of papers).
 Still, the domestic collaboration was even more prevalent, with Chile
 being the most active in such collaboration (85% of papers co-authored
 domestically) and Argentina the least active (49% of papers). We conclude
 that the Latin American countries studied are increasing their health
 biotechnology publishing. This strategy could contribute to the
 development of innovations that may solve local health problems in the
 region.
description: figures data
 baseHere is the data used to
 produce the presented figures of the article: "The rise of health
 biotechnology research in Latin America: A scientometric analysis of
 health biotechnology production and impact in Argentina, Brazil, Chile,
 Colombia, Cuba and Mexico"PLOS
 REPOSITORY.docxMain data
 baseHere is the main
 database of the paper production by the six Latin American countries
 studied in the article: "The rise of health biotechnology research in
 Latin America: A scientometric analysis of health biotechnology production
 and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico".
 The information is organized in different tabs. Each tab is identified
 with a country name.WOS PLOS
 REPOSITORY.xlsx